At AbbVie, we work every day to find potential new medications for Alzheimer's Disease. Our scientists try to further our understanding of what causes this disease so that we can develop medications that work better than what is currently available. Our study teams design and conduct clinical trials that are necessary to demonstrate whether the medications work to improve symptoms and function in patients with Alzheimer's Disease. The patients and caregivers that enroll in these trials play a pivotal role in supporting the research for new medications. We walk in support of their commitment to helping improve the lives of all Alzheimer's patients and to give hope to future generations that face this disease.